Limaye AP, Crespo M, Kamar N, Humar A, et al. Cytomegalovirus-specific cell-mediated immunity for prediction of post-prophylaxis CMV disease in a phase 3 trial of letermovir vs valganciclovir prophylaxis in donor CMV-seropositive recipient CMV-seronegative kidney transplant recipients. Clin Infect Dis 2025 Dec 1:ciaf632. doi: 10.1093.
PMID: 41321121